{
  "meta": {
    "title": "21_Disorders_Of_The_Liver",
    "url": "https://brainandscalpel.vercel.app/21-disorders-of-the-liver-dcdfc63b.html",
    "scrapedAt": "2025-11-30T12:33:06.496Z"
  },
  "questions": [
    {
      "text": "A mother observed unusual redness on the palms of her young child while putting him to sleep. She brings him to your OPD and on examination, you find mild abdominal distension, splenomegaly, and pedal edema. You admit the child for further evaluation, but on the night of admission, he suddenly starts vomiting fresh blood. Which is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Mallory Weis tear"
        },
        {
          "id": 2,
          "text": "Esophageal varices"
        },
        {
          "id": 3,
          "text": "Kala azar"
        },
        {
          "id": 4,
          "text": "AML"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A child presenting with <strong>hematemesis and splenomegaly</strong> is presumed to have <strong>variceal bleeding</strong> unless proved otherwise. Bleeding from oesophagal varices is the most common presentation of portal hypertension.</p>\n<p><strong>Palmar erythema</strong>(redness of the palms) and <strong>ascites</strong> (swelling of the abdomen) are features of liver failure seen in this patient.&nbsp;</p>\n<p>Upper GI endoscopy is the preferred diagnostic test for oesophagal varices.&nbsp;</p>\n<p>The management of acute variceal bleeding-</p>\n<ul>\n<li>Attain hemodynamic stability through blood transfusion/fluids</li>\n<li>Vasoactive drugs (e.g., <strong>octreotide</strong>)</li>\n<li>Endoscopy to perform ligation or sclerotherapy</li>\n<li>Transjugular intrahepatic portosystemic shunt should be considered for variceal bleeding refractory to medical and endoscopic therapy.&nbsp; &nbsp; &nbsp;</li>\n</ul>\n<p>Secondary prophylaxis to reduce the recurrence of bleeding includes-</p>\n<ul>\n<li>Nonselective &beta; blockade (propranolol, nadolol)</li>\n<li>Obliteration of varices through serial treatment via ligation or sclerotherapy</li>\n</ul>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5496",
      "difficulty": "medium"
    },
    {
      "text": "A 10-year-old boy was brought by his mother to the ER after having a sudden episode of vomiting blood. On examination, splenomegaly is detected with engorged superficial veins around his umbilicus. Which is the investigation of choice in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Abdominal USG"
        },
        {
          "id": 2,
          "text": "Capsule endoscopy"
        },
        {
          "id": 3,
          "text": "Triphasic CT"
        },
        {
          "id": 4,
          "text": "Upper GI endoscopy"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>A child presenting with <strong>hematemesis and splenomegaly</strong> is presumed to have <strong>variceal bleeding</strong>&nbsp;and hence,&nbsp;<strong>upper GI endoscopy&nbsp;</strong>is the investigation of choice.</p>\n<p>The upper GI endoscopy provides a definitive diagnosis and an option to treat via <strong>band ligation </strong>or<strong> sclerotherapy</strong><strong>.</strong>&nbsp;</p>\n<p>Capsule endoscopy, ultrasound, CT, MRI, and elastography are not recommended because of their suboptimal accuracy compared to endoscopy. Capsule endoscopy is used to investigate an occult/obscure gastrointestinal bleed mostly suspected to be in the small intestine.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5497",
      "difficulty": "easy"
    },
    {
      "text": "Unconjugated hyperbilirubinemia, which did not subside even after 3 weeks of birth, was observed in a neonate. On investigating, liver enzymes, PT/INR and albumin levels were normal. No hemolysis was seen on a peripheral blood smear. A drop in bilirubin level was observed within a week after treating with phenobarbital. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Rotor syndrome"
        },
        {
          "id": 2,
          "text": "Crigler Najjar type 2"
        },
        {
          "id": 3,
          "text": "Dubin Johnson syndrome"
        },
        {
          "id": 4,
          "text": "Crigler Najjar type 1"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Jaundice persisiting <strong>3 weeks after birth</strong> is suggestive of&nbsp;<strong>pathological jaundice</strong>. Among the given options,&nbsp;<strong>Crigler Najjar type</strong>&nbsp;<strong>2&nbsp;</strong>presents with&nbsp;<strong>unconjugated</strong> hyperbilirubinemia which <strong>responds</strong> to&nbsp;<strong>p</strong><strong>henobarbital therapy</strong>.<strong>&nbsp;</strong>&nbsp;</p>\n<p><strong>Dubin Johnson</strong> (option C) and <strong>Rotor&nbsp;</strong>(option A) syndromes lead to <strong>conjugated hyperbilirubinemia</strong>.&nbsp;</p>\n<p><span class=\"fontstyle0\">Crigler Najjar type 2 is an <strong>autosomal recessive</strong> disease with <strong>non-hemolytic</strong>, <strong>unconjugated</strong> hyperbilirubinemia caused by homozygous missense mutations in the enzyme UDP <strong>UGT1A1</strong>&nbsp;resulting in reduced (partial) enzymatic activity.</span></p>\n<p>The differences between Crigler-Najjar type 1 and type 2 are described in the table below:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Crigler Najjar Type 1</strong></td>\n<td>&nbsp;</td>\n<td><strong>Crigler Najjar Type 2</strong></td>\n</tr>\n<tr>\n<td>Autosomal recessive</td>\n<td>&nbsp;</td>\n<td>Autosomal recessive</td>\n</tr>\n<tr>\n<td>UDPGT is <strong>absent</strong></td>\n<td>&nbsp;</td>\n<td>UDPGT is <strong>reduced</strong></td>\n</tr>\n<tr>\n<td>Severe unconjugated hyperbilirubinemia</td>\n<td>&nbsp;</td>\n<td>Less severe</td>\n</tr>\n<tr>\n<td>Pale stools</td>\n<td>&nbsp;</td>\n<td>Normal-coloured stools</td>\n</tr>\n<tr>\n<td>May proceed to <strong>kernicterus&nbsp;</strong>and <strong>does not</strong><strong>&nbsp;respond to phenobarbitone</strong></td>\n<td>&nbsp;</td>\n<td>Does not proceed to kernicterus and <strong>is responsive to phenobarbitone</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Hereditary Hyperbilirubinemias</h3><table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Inheritance</strong></td>\n<td><strong>Defects in bilirubin metabolism</strong></td>\n<td><strong>Clinical course</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Unconjugated Hyperbilirubinemia</strong></p>\n</td>\n<td>¬†</td>\n<td>¬†</td>\n<td>¬†</td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type I</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Absent UGT1A1 activity</p>\n</td>\n<td>\n<p>Fatal in the neonatal period</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type II</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Generally mild,</p>\n<p>occasional kernicterus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gilbert syndrome</p>\n</td>\n<td>\n<p>AR (common)</p>\n<p>AD (occasional)</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Conjugated Hyperbilirubinemia</strong></p>\n</td>\n<td>¬†</td>\n<td>¬†</td>\n<td>¬†</td>\n</tr>\n<tr>\n<td>\n<p>Dubin-Johnson syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Impaired biliary excretion of bilirubin glucuronides due to a mutation in canalicular multidrug resistance protein 2 (MRP2)</p>\n</td>\n<td>\n<p>Innocuous with black pigmentation of liver</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rotor syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased hepatic uptake and storage</p>\n<p>Decreased biliary excretion</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Hyperbilirubinemia- Causes</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Predominantly Unconjugated Hyperbilirubinemia&nbsp;</strong></td>\n<td><strong>Conjugated hyperbilirubinemia</strong></td>\n</tr>\n<tr>\n<td>\n<p>Excess production of bilirubin</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Hemolytic anemias</p>\n</td>\n<td>\n<p>Biliary tract obstruction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Resorption of blood from internal hemorrhage (e.g., alimentary tract bleeding, hematomas)</p>\n</td>\n<td>\n<p>&nbsp;Biliary tract diseases like primary biliary cirrhosis and primary sclerosing cholangitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ineffective erythropoiesis (e.g., pernicious anemia, thalassemia)</p>\n</td>\n<td>\n<p>Dubin Johnson syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reduced hepatic uptake</p>\n</td>\n<td>\n<p>Rotor syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Drug interference with membrane carrier systems</p>\n</td>\n<td>Benign recurrent intrahepatic cholestasis</td>\n</tr>\n<tr>\n<td>\n<p>Some cases of Gilbert syndrome</p>\n</td>\n<td>Progressive familial intrahepatic cholestasis</td>\n</tr>\n<tr>\n<td>\n<p>Impaired bilirubin conjugation</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Physiologic jaundice of the newborn (decreased UGT1A1 activity, decreased excretion)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Breast milk jaundice (&beta;-glucuronidases in milk)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Genetic deficiency of UGT1A1 activity (Crigler-Najjar syndrome types I and II)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Gilbert syndrome</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse hepatocellular disease (e.g., viral or drug-induced hepatitis, cirrhosis)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5506",
      "difficulty": "easy"
    },
    {
      "text": "A 14-year-old boy was brought to the OPD by his father who observed a yellowish tinge to his skin and eyes. He gives a history of recent onset fatigue after playing football for a few minutes and cannot stay active on the playground for a long time like before. Investigations revealed isolated conjugated hyperbilirubinemia but are normal otherwise. Liver histology revealed a black pigment. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Gilbert syndrome"
        },
        {
          "id": 2,
          "text": "Crigler-Najjar syndrome"
        },
        {
          "id": 3,
          "text": "Dubin-Johnson syndrome"
        },
        {
          "id": 4,
          "text": "Rotor syndrome"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The presence of fatigue, conjugated hyperbilirubinemia and black pigment on liver biopsy, termed as \"<strong>black liver\"</strong>&nbsp;is suggestive of&nbsp;<strong>Dubin&ndash;Johnson syndrome</strong>.</p>\n<p>Dubin-Johnson syndrome is an <strong>autosomal recessive</strong> inherited defect in hepatocyte secretion of bilirubin glucuronide. Disease results from absent function of <strong>multiple drug-resistant protein 2</strong>,&nbsp;an ATP dependent canalicular transporter.</p>\n<p>The most commonly reported symptoms are abdominal pain and fatigue, jaundice, dark urine, and slight enlargement of the liver.</p>\n<p>Inherited conjugated hyperbilirubinemia-</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Dubin&ndash;Johnson syndrome</strong></td>\n<td><strong>Rotor syndrome</strong></td>\n</tr>\n<tr>\n<td>Autosomal recessive</td>\n<td>Autosomal recessive</td>\n</tr>\n<tr>\n<td>Absent function of<strong><strong>&nbsp;multiple drug-resistant protein (</strong></strong><strong>MRP-2)</strong></td>\n<td>Defect in anion transport</td>\n</tr>\n<tr>\n<td><strong>Black liver</strong> on biopsy (due to accumulation of epinephrine metabolite)</td>\n<td>Black liver is not seen</td>\n</tr>\n<tr>\n<td>Normal levels of coproporphyrin in urine</td>\n<td>Increased levels of coproporphyrin in urine&nbsp;</td>\n</tr>\n<tr>\n<td>Gall bladder is not visualized on oral cholecystography</td>\n<td>Gall bladder is visualized on oral cholecystography</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5565",
      "difficulty": "easy"
    },
    {
      "text": "You are an intern posted in the paediatrics department and a child with Dubin-Johnson syndrome is admitted to your unit. During rounds, the attending paediatrician asks you which molecular defect causes liver disease in this patient. Your answer would be",
      "choices": [
        {
          "id": 1,
          "text": "ATP7A"
        },
        {
          "id": 2,
          "text": "ATP7B"
        },
        {
          "id": 3,
          "text": "ABCC2"
        },
        {
          "id": 4,
          "text": "SERPINA 1"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Molecular defect causing liver disease in <strong>Dubin&ndash;Johnson syndrome</strong>&nbsp;is<strong> ABCC2</strong> (codes for canalicular protein with ATP-binding cassette), it leads to the mutation of <strong>multiple drug-resistant protein 2 (MRP2) receptor</strong>. Hence, there is&nbsp;a defect in the&nbsp;transfer of conjugated bilirubin from the&nbsp;liver to bile in Dubin&ndash;Johnson syndrome.</p>\n<p>Important diseases and their molecular defects:</p>\n<table>\n<tbody>\n<tr>\n<td>ATP7A&nbsp;</td>\n<td>Menke&rsquo;s&nbsp;disease&nbsp;</td>\n</tr>\n<tr>\n<td>ATP7B&nbsp;</td>\n<td>Wilson disease&nbsp;</td>\n</tr>\n<tr>\n<td>CFTR&nbsp;</td>\n<td>Cystic fibrosis&nbsp;</td>\n</tr>\n<tr>\n<td>SERPINA 1&nbsp;</td>\n<td>&alpha;-1 antitrypsin deficiency&nbsp;</td>\n</tr>\n<tr>\n<td>ABCC2&nbsp;(MRP2 protein defect)&nbsp;</td>\n<td>Dubin&nbsp;Johnson syndrome&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9301",
      "difficulty": "medium"
    },
    {
      "text": "All are true about transient familial neonatal hyperbilirubinemia, except:",
      "choices": [
        {
          "id": 1,
          "text": "Increased unconjugated bilirubin"
        },
        {
          "id": 2,
          "text": "Occurs due to maternal antibody against fetal UGT1A1"
        },
        {
          "id": 3,
          "text": "It is also known as Lucey Driscoll syndrome"
        },
        {
          "id": 4,
          "text": "Stop breast feeding when jaundice sets in"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Lucey Driscoll syndrome</strong> or <strong>transient familial neonatal hyperbilirubinemia</strong> is a self-limiting condition and there is <strong>no need to stop breastfeeding. </strong></p>\n<p><strong>Lucey Driscoll syndrome</strong>&nbsp;is an autosomal recessive metabolic disorder affecting enzymes involved in <strong>bilirubin metabolism</strong>. It causes transient familial neonatal unconjugated hyperbilirubinemia and <strong>jaundice</strong> occurs during the <strong>first 4 days of life</strong>. It is due to <strong>maternal antibodies</strong> against <strong>fetal UGT1A1</strong>&nbsp;(UDP glucuronosyltransferase family 1 member A1).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6905",
      "difficulty": "easy"
    },
    {
      "text": "Lately, a teacher observed that an anxious young girl had started drooling saliva from her mouth while listening in the classroom. She had also developed a deterioration in her handwriting while taking down notes. Her mother was informed and she brought her child to your clinic. On examination, she had tremors and mild hepatomegaly. A slit-lamp examination was done and showed the following picture. The right statement about this disease is -",
      "choices": [
        {
          "id": 1,
          "text": "It is autosomal dominant."
        },
        {
          "id": 2,
          "text": "Serum ceruplasmin levels are high."
        },
        {
          "id": 3,
          "text": "Coombs-positive hemolytic anaemia may be present."
        },
        {
          "id": 4,
          "text": "Patient can be treated with triethylenetetramine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The image shows the <strong>Kayser-Fleischer ring</strong>, which is characteristic of <strong>Wilson's disease</strong>. It is an <strong>autosomal recessive</strong> disorder, characterised by <strong>low serum ceruloplasmin</strong> levels. <strong>Coomb's negative hemolytic anemia</strong> may be present. The patient can be treated with <strong>triethylenetetramine</strong> also known as <strong>trientine</strong>.</p>\n<p>Wilson&rsquo;s disease is caused due to a&nbsp;<strong>loss-of-function mutation</strong>&nbsp;in the&nbsp;<strong>ATP7B</strong>&nbsp;gene on&nbsp;<strong>Chr.13q</strong>. The gene encodes a copper transporting ATPase (ATP7B) which has 2 functions:</p>\n<ul>\n<li aria-level=\"1\">Maintains copper in bound form by binding copper to apoceruloplasmin</li>\n<li aria-level=\"1\">Helps excrete free copper in bile.</li>\n</ul>\n<p>Thus, an ATP7B deficiency leads to&nbsp;<strong>excess deposition of free copper</strong>&nbsp;within tissues.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Lab markers</strong></td>\n<td><strong>Change in Wilson's disease</strong></td>\n<td><strong>Reason</strong></td>\n</tr>\n<tr>\n<td>Serum ceruloplasmin</td>\n<td>&darr;&darr;</td>\n<td>ATP7B deficiency results in reduced bound copper</td>\n</tr>\n<tr>\n<td>24h urinary copper</td>\n<td>&uarr;&uarr;</td>\n<td>Excess free copper excreted in urine</td>\n</tr>\n<tr>\n<td>Total serum copper</td>\n<td>&darr;</td>\n<td>Due to marked reduction in ceruloplasmin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The drugs used in the management of Wilson's disease include:</p>\n<ul>\n<li>Chelating agents as first-line drugs\n<ul>\n<li><strong>D-penicillamine</strong></li>\n<li><strong>Trientine&nbsp;</strong>or&nbsp;triethylenetetramine</li>\n</ul>\n</li>\n<li>Elemental&nbsp;<strong>zinc</strong>&nbsp;as maintenance therapy.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f4958c7582ad4ddbb7614dd1d63f1f1d.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1126",
      "difficulty": "hard"
    },
    {
      "text": "A mother observed deterioration in her young child's academic performance and loss of interest in everyday activities for the last few weeks. She has also lost the ability to play catch with her brother and complains of muscle weakness. There is mild hepatomegaly noted on examination. Her serum ceruloplasmin levels were reduced. All of the following manifestations can occur in a patient with this disease except?",
      "choices": [
        {
          "id": 1,
          "text": "Sparse depigmented hair"
        },
        {
          "id": 2,
          "text": "Shrinkage of liver"
        },
        {
          "id": 3,
          "text": "Ascites and portal hypertension"
        },
        {
          "id": 4,
          "text": "Renal Fanconi syndrome"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The presence of <strong>reduced ceruloplasmin</strong> levels, <strong>motor incoordination,</strong> and <strong>hepatomegaly</strong> suggest the patient is suffering from <strong>Wilson‚Äôs disease.¬†</strong><strong>Sparse depigmented hair</strong> is <strong>not</strong> a feature of Wilson's disease. It is a feature of <strong>Menke's disease.</strong></p>\n<p>Wilson's disease is caused due to a mutation in the <strong>ATP7B gene</strong> that leads to¬†<strong>excess deposition of free copper</strong>¬†within tissues.</p>\n<p>It has the following clinical features:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>System</strong></td>\n<td><strong>Clinical features</strong></td>\n</tr>\n<tr>\n<td>Hepatic<br />(most common)</td>\n<td>\n<p>Jaundice<br />Abdominal pain<br />Hepatomegaly<br />Fatigue<br />Ascites<br />Variceal bleed<br />Coagulation defects</p>\n</td>\n</tr>\n<tr>\n<td>Neurological</td>\n<td>Dysarthria<br />Dystonia<br />Parkinsonism<br />Subcortical dementia<br />Depression<br />Wing beating tremors<br />Decreased scholastic performance</td>\n</tr>\n<tr>\n<td>Ophthalmic</td>\n<td>Kayser-Fleischer (KF) rings<br />Sunflower cataract</td>\n</tr>\n<tr>\n<td>Others</td>\n<td>Hemolytic anemia (Coombs negative)<br />Acute pancreatitis<br />Fanconi's syndrome<br />Hyperparathyroidism<br />Cardiomyopathy<br />Spontaneous abortions<br />Infertility</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: Wilson's disease may also present as cirrhosis and hepatic failure, where shrinkage of liver occurs.</p><hr><h3>Related Pearl: Menkes disease</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3f0c58fe358940b393c96afe12ef3455x1280x1951.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5568",
      "difficulty": "medium"
    },
    {
      "text": "In Wilson Disease, hepatic copper content usually exceeds____ Œºg/g dry weight.",
      "choices": [
        {
          "id": 1,
          "text": "150"
        },
        {
          "id": 2,
          "text": "250"
        },
        {
          "id": 3,
          "text": "350"
        },
        {
          "id": 4,
          "text": "450"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In Wilson disease, <strong>hepatic copper content</strong> usually exceeds<strong> 250 &mu;g/g </strong>dry weight.</p>\n<p><strong>Hepatic copper accumulation </strong>is the<strong> hallmark </strong>of Wilson disease.&nbsp;It is measured using neutron activation analysis/atomic absorption spectrometry.&nbsp;&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5573",
      "difficulty": "easy"
    },
    {
      "text": "A male infant was born to a mother with chronic hepatitis B infection. The infant is suspected to have been exposed at the time of delivery. At 4 months, which of the following viral markers signifies ongoing viral replication in the infant?",
      "choices": [
        {
          "id": 1,
          "text": "Anti-HBs"
        },
        {
          "id": 2,
          "text": "Anti-HBc"
        },
        {
          "id": 3,
          "text": "HBe Ag"
        },
        {
          "id": 4,
          "text": "HBs Ag"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>HBeAg</strong> signifies the ongoing viral replication in case of hepatitis B infection.</p><hr><h3>Related Pearl: Interpretation of common serologic patterns in hepatitis B infection</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5552cae694994040b6b13be6442fc5adx1280x1466.JPEG\" alt=\"Pearl Image\"><p>¬†</p>\n<table>\n<tbody>\n<tr>\n<td>¬†<strong>Clinical Phases</strong></td>\n<td><span><strong>HBsAg</strong></span></td>\n<td><span><strong>Anti-HBs</strong></span></td>\n<td><span><strong>HBeAg</strong></span></td>\n<td><span><strong>Anti-HBe</strong></span></td>\n<td><span><strong>Anti-HBc</strong></span></td>\n<td><span><strong>HBV DNA</strong></span></td>\n</tr>\n<tr>\n<td><span>Acute HBV - Early-phase, high infectivity</span></td>\n<td>\n<p><span>+</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV -</span><span>Window phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgM</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV - recovery phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>+/-</span></td>\n</tr>\n<tr>\n<td><span>Chronic HBV, high infectivity</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Chronic HBV, low infectivity</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the recent past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the remote past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-vaccination</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: The Hepatitis Viruses</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>HAV</td>\n<td>HBV</td>\n<td>HCV</td>\n<td>HDV</td>\n<td>HEV</td>\n</tr>\n<tr>\n<td>Specific name</td>\n<td>Hepatovirus A</td>\n<td>Hepatitis B virus</td>\n<td>Hepacivirus C</td>\n<td>Hepatitis D virus</td>\n<td>Orthohepevirus A</td>\n</tr>\n<tr>\n<td>Family</td>\n<td>Picornaviridae</td>\n<td>Hepadnaviridae</td>\n<td>Flaviviridae</td>\n<td>Kolmioviridae (genus deltavirus)</td>\n<td>Hepeviridae</td>\n</tr>\n<tr>\n<td>Envelope</td>\n<td>Non enveloped</td>\n<td>Enveloped</td>\n<td>Enveloped</td>\n<td>Envelope from HBV</td>\n<td>Quasi-enveloped</td>\n</tr>\n<tr>\n<td>Nuclear material</td>\n<td>ssRNA</td>\n<td>Partially dsDNA</td>\n<td>ssRNA</td>\n<td>Circular defective ssRNA</td>\n<td>ssRNA</td>\n</tr>\n<tr>\n<td>Antigens</td>\n<td>HAV Ag</td>\n<td>HBsAg, HBcAg, HBeAg, HBxAg</td>\n<td>HCV Ag</td>\n<td>HBsAg, HDAg</td>\n<td>HEV Ag</td>\n</tr>\n<tr>\n<td>Antibodies</td>\n<td>Anti-HAV Ab</td>\n<td>Anti-HBs Ab, Anti-HBc Ab, Anti-HBe Ab</td>\n<td>Anti-HCV Ab</td>\n<td>Anti-HBs Ab, Anti-HDV Ab</td>\n<td>Anti-HEV Ab</td>\n</tr>\n<tr>\n<td>Auto-antibodies</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>Anti-LKM 1</td>\n<td>Anti-LKM 3</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Routes of transmission</td>\n<td>Feco-oral, parenteral, sexual</td>\n<td>Perinatal, parenteral, sexual, percutaneous, direct mucosal contact</td>\n<td>Parenteral, perinatal, percutaneous, sexual</td>\n<td>Parenteral, sexual</td>\n<td>Feco-oral, zoonotic, vertical</td>\n</tr>\n<tr>\n<td>Incubation period</td>\n<td>30 days</td>\n<td>60 days</td>\n<td>50 days</td>\n<td>60 days</td>\n<td>40 days</td>\n</tr>\n<tr>\n<td>Chances of fulminant hepatic failure</td>\n<td>0.1%</td>\n<td>0.1 to 1%</td>\n<td>0.1%</td>\n<td>5% in coinfections and 20% in superinfections</td>\n<td>1-2% in adults and up to 25% in pregnant women</td>\n</tr>\n<tr>\n<td>Extrahepatic manifestations</td>\n<td>Rash, arthralgia</td>\n<td>Polyarteritis nodosa and membranous nephropathy</td>\n<td>Essential mixed cryoglobulinemia, MPGN, Metabolic syndrome</td>\n<td>&nbsp; &nbsp; &nbsp; -</td>\n<td>GBS, Bell&rsquo;s palsy, pancreatitis, &nbsp;and glomerulonephritis</td>\n</tr>\n<tr>\n<td>Resolution of acute infection</td>\n<td>2 months</td>\n<td>6 months</td>\n<td>6 months</td>\n<td>6 months</td>\n<td>3 months</td>\n</tr>\n<tr>\n<td>Progression to chronic infection</td>\n<td>No</td>\n<td>5-10%</td>\n<td>&gt;80%</td>\n<td>\n<p>10% of co-infections,</p>\n<p>90&ndash;100% of superinfections</p>\n</td>\n<td>\n<p>Only in immuno-compromised</p>\n</td>\n</tr>\n<tr>\n<td>HCC</td>\n<td>No</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n</tr>\n<tr>\n<td>Vaccine</td>\n<td>Available</td>\n<td>Available</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>\n<td>HBV vaccine</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; -</td>\n</tr>\n<tr>\n<td>Therapy</td>\n<td>None</td>\n<td>Entecavir, tenofovir, pegIFN-ùõÇ</td>\n<td>Velpatasvir, sofosbuvir, ribavirin</td>\n<td>PegIFN-ùõÇ</td>\n<td>None</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5575",
      "difficulty": "medium"
    },
    {
      "text": "A 9-year-old boy was brought to the OPD by his mother with a history of fatigue and myalgia for a few days, associated with rashes that started a week before it. On examination, coppery-red coloured skin lesions were seen on the face and limbs including palms and soles. His serology was positive for HBsAg. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Erythema infectiosum"
        },
        {
          "id": 2,
          "text": "Gianotti- Crosti syndrome"
        },
        {
          "id": 3,
          "text": "Henoch schonlein purpura"
        },
        {
          "id": 4,
          "text": "Erythema multiformae"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The coppery-red colored papules along with a <strong>positive HBsAg</strong> are suggestive of <strong>Gianotti-Crosti syndrome</strong>, also known as papular acrodermatitis.</p>\n<p>It is an immunologic reaction to viral infections. The most common associations are Epstein-Barr virus,<strong>&nbsp;hepatitis B virus</strong>, Coxsackievirus A16, and parainfluenza virus, as well as with many childhood immunizations.</p>\n<p>Skin lesions are monomorphic, firm, coppery red papules sized 1-10 mm. They occur in crops and may become profuse and coalesce into plaques, forming a symmetric eruption on the face, ears, buttocks, and limbs, including the palms and soles. The trunk, scalp, and mucous membrane are relatively spared.</p>\n<p>The image given below shows the coppery red papules seen in Gianotti-Crosti syndrome.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d3d198ab8f874b66b23876ab97587128x603x438.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5576",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs are not used in the treatment of hepatitis B?",
      "choices": [
        {
          "id": 1,
          "text": "Interferon Œ±2b"
        },
        {
          "id": 2,
          "text": "Lamivudine"
        },
        {
          "id": 3,
          "text": "Adefovir"
        },
        {
          "id": 4,
          "text": "Ribavirin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Ribavirin</strong> is a drug used in the treatment of <strong>hepatitis C</strong>,¬†not hepatitis B.</p>\n<p>Indications for starting antiviral therapy in chronic hepatitis B are:</p>\n<ul>\n<li aria-level=\"1\">Patients without cirrhosis</li>\n<ul>\n<li aria-level=\"2\">HBeAg + with HBV DNA &gt;20,000 IU/mL and ALT level &gt;2 times the upper limit of normal</li>\n<li aria-level=\"2\">HBeAg -ve with HBV DNA &gt;2000 IU/mL and ALT level &gt;2 times the upper limit of normal</li>\n</ul>\n<li aria-level=\"1\">Patients with compensated cirrhosis and an HBV DNA &gt;2000 IU/mL</li>\n<li aria-level=\"1\">Patients developing acute liver failure or decompensated cirrhosis.</li>\n</ul>\n<p>Drugs used in the treatment of hepatitis B are:</p>\n<ul>\n<li>First-line treatment: Entecavir or tenofovir¬†</li>\n<li aria-level=\"1\">Other drugs:\n<ul>\n<li aria-level=\"1\"><strong>Pegylated interferon-alpha</strong>¬†</li>\n<li aria-level=\"1\">Telbivudine</li>\n<li aria-level=\"1\"><strong>Lamivudine</strong></li>\n<li aria-level=\"1\"><strong>Adefovir</strong></li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5577",
      "difficulty": "medium"
    },
    {
      "text": "A young child developed sudden bouts of vomiting and was brought to the ER.  Her condition rapidly worsened as she developed seizures. She had a history of influenza infection one week ago. The patient's liver biopsy will show ______.",
      "choices": [
        {
          "id": 1,
          "text": "Non-alcoholic steatohepatitis (NASH)"
        },
        {
          "id": 2,
          "text": "Centri zonal hemorrhagic necrosis"
        },
        {
          "id": 3,
          "text": "Marked microvesicular steatotis"
        },
        {
          "id": 4,
          "text": "Ring granuloma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Severe vomiting in a 5-year-old child, rapidly worsening to seizures, with a history of viral infection (influenza) is suggestive of <strong>Reye's syndrome.</strong> Hence, liver biopsy will show<strong> marked microvesicular steatosis</strong>.</p>\n<p>Reye's syndrome&nbsp;is a secondary mitochondrial hepatopathy. It is precipitated due to</p>\n<ul>\n<li>Viral infection (<strong>influenza, adenovirus, herpes, </strong>coxsackievirus A, Epstein&ndash;Barr virus)</li>\n<li><strong>Salicylate</strong> or antiemetic use</li>\n<li>Inborn error of metabolism such as <strong>single enzyme defects of &szlig; oxidation.</strong></li>\n<li>Toxins</li>\n</ul>\n<p>There is an acute onset of vomiting and encephalopathy, rapidly progressing to seizures, coma,&nbsp;and death. There is<strong> no jaundice</strong>.</p>\n<p>Investigations</p>\n<ul>\n<li>&uarr; ALT and AST</li>\n<li>&uarr; Ammonia</li>\n<li>normal bilirubin</li>\n<li>Hypoglycemia</li>\n<li>PT prolonged</li>\n<li>INR increased</li>\n<li>Liver biopsy: marked microvesicular steatosis. Necrosis is not seen.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1086",
      "difficulty": "hard"
    },
    {
      "text": "A 12-year old girl was rushed to the ER by her parents due to hematemesis. They gave a history of weakness and fatigue for the last few weeks. On examination, the patient had spider telangiectasias and mild palmar erythema. Liver function tests showed the following results- AST-1100IU/L, serum bilirubin- 8mg/dl, albumin- decreased, globulin- elevated, PT- prolonged along with Anti-Nuclear Antibody positive. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Type 1 autoimmune hepatitis"
        },
        {
          "id": 2,
          "text": "SLE"
        },
        {
          "id": 3,
          "text": "Type 2 autoimmune hepatitis"
        },
        {
          "id": 4,
          "text": "Hepatitis C"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The symptoms of liver failure and portal hypertension along with a positive anti-nuclear antibody<strong>(ANA)</strong> is suggestive of Type 1 autoimmune hepatitis. It is associated with-&nbsp;</p>\n<ul>\n<li>Elevated serum aminotransaminase concentrations.</li>\n<li>Liver-associated serum autoantibodies<strong>.</strong></li>\n<li>Hypergammaglobulinemia.</li>\n</ul><hr><h3>Related Pearl: Antibodies in Hepatitis</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Antibodies </strong></td>\n<td><strong>Seen in </strong></td>\n</tr>\n<tr>\n<td>\n<p>ANA, ASMA, pANCA, anti-SLA/LP, AMA</p>\n</td>\n<td>\n<p>Autoimmune hepatitis Type 1</p>\n</td>\n</tr>\n<tr>\n<td>Anti-liver cytosol 1</td>\n<td>\n<p>Autoimmune hepatitis Type 2</p>\n</td>\n</tr>\n<tr>\n<td>Anti-LKM 1</td>\n<td>\n<p>Autoimmune hepatitis Type 2&nbsp;</p>\n<p>Chronic hepatitis C</p>\n</td>\n</tr>\n<tr>\n<td>Anti-LKM 2</td>\n<td>Drug-induced hepatitis</td>\n</tr>\n<tr>\n<td>Anti-LKM 3</td>\n<td>\n<p>Chronic hepatitis D</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>ANA: Anti-nuclear antibodies (most common antibody in autoimmune hepatitis)</li>\n<li>LKM: Liver&ndash;kidney microsomes</li>\n<li>SLA/LP: Soluble liver antigen/liver-pancreas</li>\n<li>ASMA: Anti-smooth muscle actin</li>\n<li>pANCA: Perinuclear anti-neutrophil cytoplasmic antibodies</li>\n<li>AMA: Antimitochondrial antibodies</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5579",
      "difficulty": "medium"
    },
    {
      "text": "A 2-week-old low-birth-weight neonate presents with jaundice. Stools are pale/clay coloured. Liver biopsy shows loss of architecture. The most likely diagnosis is_______.",
      "choices": [
        {
          "id": 1,
          "text": "Neonatal hepatitis"
        },
        {
          "id": 2,
          "text": "Extrahepatic biliary atresia"
        },
        {
          "id": 3,
          "text": "Wilson disease"
        },
        {
          "id": 4,
          "text": "Hereditary hemochromatosis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Neonatal jaundice in a low-birth-weight (LBW) neonate with consistently pale/clay coloured stools with liver biopsy finding of loss of architecture is suggestive of <strong>neonatal hepatitis</strong>.</p>\n<p>Wilson disease and hereditary hemochromatosis will not present with jaundice in the neonatal stage. Hence, they can be excluded.&nbsp;Injury to liver cells can present the clinical and histologic picture of &ldquo;neonatal hepatitis.&rdquo;</p>\n<p>Differentiation between Neonatal hepatitis and EHBA</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Neonatal hepatitis&nbsp;</strong></td>\n<td><strong>Extrahepatic biliary atresia (EHBA)&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Definition</strong></td>\n<td>\n<p>It implies intrahepatic cholestasis which includes</p>\n<ul>\n<li>Hepatic injury due to metabolic, viral, or idiopathic causes</li>\n<li>Intrahepatic bile duct injury</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Obliteration of&nbsp;the entire extrahepatic biliary tree at or above the porta hepatis(85% cases) OR</li>\n<li>distal segmental bile duct obliteration with patent<br />extrahepatic ducts up to the porta hepatis(uncommon)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Clinical features&nbsp;</strong></td>\n<td>\n<p>Family history is present</p>\n<p>Premature or LBW baby</p>\n<p>Clay-coloured stools&nbsp;</p>\n</td>\n<td>\n<p>Family history absent</p>\n<p>Normal appearance, without looking sick</p>\n<p>Persistent acholic&nbsp;stools&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Investigations</strong></td>\n<td>Liver biopsy: Loss of liver architecture&nbsp;</td>\n<td>\n<p>HIDA scan: screening test&nbsp;</p>\n<p>USG:&nbsp;triangular cord sign&nbsp;</p>\n<p>Liver biopsy: bile duct proliferation&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5581",
      "difficulty": "medium"
    },
    {
      "text": "A mother is concerned about her 3-week-old baby having yellowish discolouration of skin and eyes. On examination, the baby is chubby and playful. Stools are pale in color. Further evaluation with USG shows triangular cord sign and liver biopsy shows bile duct proliferation. The most likely diagnosis is ______.",
      "choices": [
        {
          "id": 1,
          "text": "Neonatal hepatitis"
        },
        {
          "id": 2,
          "text": "Hallervorden Spatz disease"
        },
        {
          "id": 3,
          "text": "Wilson disease"
        },
        {
          "id": 4,
          "text": "Extrahepatic biliary atresia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Neonatal jaundice in a neonate <strong>without a sick-looking appearance and&nbsp;with</strong> <strong>acholic stools,&nbsp;</strong>USG showing <strong>triangular cord sign,</strong> and liver biopsy showing<strong> bile duct proliferation</strong>&nbsp;is&nbsp;suggestive of biliary obstruction, which may be seen in <strong>biliary atresia</strong>.</p>\n<p>Wilson disease and Hallervorden Spatz disease (neurodegeneration with iron accumulation in the brain) do not present with jaundice in the neonatal stage. Hence, they can be excluded.</p>\n<p>Differentiation between neonatal hepatitis and EHBA</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Neonatal hepatitis&nbsp;</strong></td>\n<td><strong>Extrahepatic biliary atresia (EHBA)&nbsp;</strong></td>\n</tr>\n<tr>\n<td>\n<p>It implies intrahepatic cholestasis which includes:</p>\n<p>Hepatic injury due to metabolic, viral, or idiopathic cause</p>\n<p>Intrahepatic bile duct injury</p>\n</td>\n<td>\n<p>Obliteration of&nbsp;the entire extrahepatic biliary tree at or above the porta hepatis(85% cases)&nbsp; OR</p>\n<p>Distal segmental bile duct obliteration with patent<br />extrahepatic ducts up to the porta hepatis (uncommon)</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">&nbsp;<strong>Clinical features&nbsp;</strong></td>\n</tr>\n<tr>\n<td>\n<p>Family history is present</p>\n<p>Premature or LBW baby</p>\n<p>Pigmented stools&nbsp;</p>\n</td>\n<td>\n<p>Family history absent</p>\n<p>Normal appearance, without looking sick</p>\n<p>Persistent acholic&nbsp;stools&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p><strong>Investigations</strong></p>\n</td>\n</tr>\n<tr>\n<td>Liver biopsy: Loss of liver architecture&nbsp;</td>\n<td>\n<p>USG:&nbsp;triangular cord sign</p>\n<p>HIDA scan: screening test&nbsp;</p>\n<p>Liver biopsy: bile duct proliferation&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Liver biospy:</strong></p>\n<ul>\n<li>Biliary atresia is characterized by proliferation&nbsp;of the bile ductule, presence of bile plugs, and portal or perilobular edema and fibrosis, with the&nbsp;<strong>basic hepatic lobular architecture intact</strong>.</li>\n<li>In neonatal hepatitis, there is severe, diffuse hepatocellular disease, with<strong>&nbsp;distortion of lobular architecture</strong>, marked infiltration of inflammatory cells, and focal hepatocellular necrosis.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5582",
      "difficulty": "easy"
    },
    {
      "text": "A mother leaves her 3-year-old son unattended for 20 mins and later finds him holding a blue coloured empty strip of tablets with a few tablets scattered on the floor. A few hours later he is rushed to the ER with nausea and vomiting.  As an intern taking the history, you suspect accidental ingestion of paracetamol tablets. The pattern of liver injury you would expect in this case is",
      "choices": [
        {
          "id": 1,
          "text": "Cholestasis"
        },
        {
          "id": 2,
          "text": "Centrilobular necrosis"
        },
        {
          "id": 3,
          "text": "Microvesicular steatosis"
        },
        {
          "id": 4,
          "text": "Fibrosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The pattern of liver injury caused by paracetamol (acetaminophen) is <strong>centrilobular necrosis</strong>.</p>\n<p>Acetaminophen toxicity results from the formation of a highly reactive intermediate metabolite, N -acetyl-p -benzoquinone imine (<strong>NAPQI</strong>). In therapeutic use, only about 5% is metabolized by the hepatic <strong>cytochrome P450</strong> enzyme CYP2E1 to NAPQI, which is then immediately joined with glutathione to form a nontoxic mercapturic acid conjugate.</p>\n<p>In overdose, glutathione stores are overwhelmed, and free NAPQI is able to combine with hepatic macromolecules to produce <strong>hepatocellular necrosis</strong>. Single acute toxic dose of APAP is generally considered to be <strong>&gt;200 mg/kg</strong> in children.&nbsp;</p>\n<p>Patterns of hepatic drug injury:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disease&nbsp;</strong></td>\n<td><strong>Drug&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Centrilobular&nbsp;necrosis&nbsp;</strong></td>\n<td><strong>Acetaminophen,</strong>&nbsp;Halothane&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Microvesicular&nbsp;steatosis&nbsp;</strong></td>\n<td><strong>Valproic&nbsp;acid&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Acute hepatitis&nbsp;</td>\n<td>Isoniazid&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Fibrosis&nbsp;</strong></td>\n<td><strong>Methotrexate&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Cholestasis&nbsp;</strong></td>\n<td>Chlorpromazine,&nbsp;<strong>Erythromycin,&nbsp;</strong>Estrogen&nbsp;</td>\n</tr>\n<tr>\n<td>Veno&nbsp;occlusive disease&nbsp;</td>\n<td>Busulphan, Cyclophosphamide&nbsp;</td>\n</tr>\n<tr>\n<td>Portal and hepatic vein thrombosis&nbsp;</td>\n<td>Estrogen, Androgen&nbsp;</td>\n</tr>\n<tr>\n<td>Biliary sludge&nbsp;</td>\n<td>Ceftriaxone&nbsp;</td>\n</tr>\n<tr>\n<td>Hepatic adenoma/hepatocellular carcinoma&nbsp;</td>\n<td>Oral contraceptive pills, Anabolic steroids&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5583",
      "difficulty": "medium"
    },
    {
      "text": "You are examining a young child who presented to the ER with a high fever and abdominal pain. The patient winces on abdominal palpation of the right upper quadrant. USG showed hydrops of the gallbladder. All of the following conditions are associated with hydrops of the gallbladder except\n__________.",
      "choices": [
        {
          "id": 1,
          "text": "Group A streptococcal pharyngitis"
        },
        {
          "id": 2,
          "text": "Kawasaki disease"
        },
        {
          "id": 3,
          "text": "Total parenteral nutrition"
        },
        {
          "id": 4,
          "text": "Cystic fibrosis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Hydrops of the&nbsp;gallbladder is<strong> not</strong> associated with<strong>&nbsp;cystic fibrosis</strong>.</p>\n<p>Hydrops of gallbladder is the acute acalculous <strong>non-inflammatory</strong> distension of the gallbladder, which occurs in infants and children. It is characterized by the absence of calculi, bacterial infections or congenital anomalies of the biliary system.</p>\n<p>Hydrops is distinguished from acalculous cholecystitis by the absence of a significant inflammatory process and a generally <strong>benign prognosis</strong>.</p>\n<p>Conditions associated with hydrops of GB:</p>\n<ul>\n<li>Infections: <strong>Streptococcal pharyngitis</strong>, staphylococcal infection, ascariasis, leptospirosis, typhoid fever,&nbsp;and viral hepatitis</li>\n<li><strong>Kawasaki disease </strong></li>\n<li><strong>Total parenteral nutrition, prolonged fasting</strong></li>\n<li>Sickle cell crisis, thalassemia</li>\n<li>Sepsis</li>\n<li>Mesenteric adenitis, necrotizing enterocolitis</li>\n</ul>\n<p>Note: In cystic fibrosis&nbsp;cholelithiasis, cholecystitis, micro gallbladder is seen.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5584",
      "difficulty": "hard"
    },
    {
      "text": "The commonest indication for liver transplantation in children is ______",
      "choices": [
        {
          "id": 1,
          "text": "Alagille syndrome"
        },
        {
          "id": 2,
          "text": "Biliary atresia"
        },
        {
          "id": 3,
          "text": "Caroli disease"
        },
        {
          "id": 4,
          "text": "Hepatcellular carcinoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Biliary atresia</strong> is the <strong>most common</strong> indication for<strong> liver transplantation in children</strong>.</p>\n<p>Extrahepatic biliary atresia&nbsp;(EHBA) is defined as a partial or total <strong>absence </strong>of permeable<strong> bile duct </strong>between the porta hepatis and the duodenum. It is due to <strong>inflammatory fibrosis</strong> of the biliary tree.&nbsp;It leads to obstruction to bile flow thereby causing the leaking of <strong>conjugated bilirubin</strong> into the circulation.</p>\n<p>Infants have symptoms of <strong>jaundice</strong>,<strong> pale stools</strong>, and <strong>dark urine</strong> right after birth. In advanced disease, infants present with failure to thrive, hepatomegaly, and ascites due to liver cirrhosis.</p>\n<p><strong>HIDA scan</strong>&nbsp;is the <strong>investigation of choice</strong> for extrahepatic biliary atresia. An<strong> intraoperative cholangiogram </strong>is a gold standard investigation for diagnosis.</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"3\"><strong>Management of extrahepatic biliary atresia</strong></td>\n</tr>\n<tr>\n<td>Type I</td>\n<td>\n<div class=\"page\" title=\"Page 1217\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Atresia restricted to the common bile duct</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 1217\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Roux-en-Y hepaticojejunostomy</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>Type II</td>\n<td>\n<div class=\"page\" title=\"Page 1217\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Atresia of the common hepatic duct</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td rowspan=\"2\"><strong>Kasai procedure</strong> (Roux-en-Y hepatoportoenterostomy)</td>\n</tr>\n<tr>\n<td>Type III</td>\n<td>\n<div class=\"page\" title=\"Page 1217\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Atresia of the right and left hepatic duct</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Children with biliary atresia, who do not achieve successful drainage after hepatoportoenterostomy (<strong>Kasai's procedure</strong>), require liver transplantation within the first year of life.</p><hr><h3>Related Pearl: Indications of liver transplantation</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Adult</strong></p>\n</td>\n<td>\n<p><strong>Children</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Non-cholestatic (65%)</p>\n<ul>\n<li>Viral hepatitis B and C</li>\n<li>Alcoholic liver cirrhosis</li>\n<li>Cryptogenic</li>\n</ul>\n<p>Cholestatic (14%)</p>\n<ul>\n<li>Primary biliary cirrhosis</li>\n<li>Primary sclerosing cholangitis</li>\n</ul>\n<p>Autoimmune (5%)</p>\n<p>Malignant neoplasm (2%)</p>\n<p>Miscellaneous (14%)</p>\n</td>\n<td>\n<p>Biliary atresia (58%)</p>\n<p>Inborn errors of metabolism (11%)</p>\n<p>Cholestatic (9%)</p>\n<ul>\n<li>Primary sclerosing cholangitis</li>\n<li>Alagille syndrome</li>\n</ul>\n<p>Autoimmune (4%)</p>\n<p>Viral hepatitis (2%)</p>\n<p>Miscellaneous (16%)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5585",
      "difficulty": "easy"
    },
    {
      "text": "A young boy was admitted with complaints of fever and abdominal pain for 2 days. ESR and CRP were elevated and CT Abdomen obtained was as shown in the picture. Which of the following is not a common feature in the given condition?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatomegaly"
        },
        {
          "id": 2,
          "text": "Hypoalbuminemia"
        },
        {
          "id": 3,
          "text": "Jaundice"
        },
        {
          "id": 4,
          "text": "Leukocytosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The symptoms of fever and abdominal pain and a hypodense lesion on the CT are suggestive of a Liver abscess in this patient.&nbsp;</p>\n<p>Signs and symptoms of a liver abscess include fever, chills, night sweats, malaise, nausea, hepatomegaly, as well as&nbsp;pain and tenderness in the right upper quadrant. They also show elevated inflammatory markers, hypoalbuminemia and leukocytosis. However, <strong>jaundice is uncommon</strong>.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b5b1e5f058654445ac28e5ed9783bc00.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5586",
      "difficulty": "medium"
    }
  ]
}